Medical Devices

A German biotech's novel oral drug for herpes is moving to Phase 2 trials, offering new hope against a widespread and often resistant virus.

The FDA has qualified MolecuLightDX's measurement tool, a move set to standardize clinical trials, accelerate innovation, and redefine wound healing.

ENA Respiratory's INNA-051 nasal spray, a virus-agnostic shield, has begun Phase II trials, offering new hope for high-risk communities.

With new board members from J&J MedTech and key VCs, the firm is set to scale its real-time AI-powered tissue imaging platform for cancer diagnostics.

The Spanish pharma giant secures approval for the first oral antibiotic specifically for acne in China, targeting a multi-billion dollar dermatology market.

Laborie's major acquisition brings a life-saving device for postpartum hemorrhage into its portfolio, aiming to reduce maternal deaths worldwide.

CompuGroup Medical's new AI tool aims to slash administrative work, but can it solve the burnout crisis and give doctors back their time with patients?

Natus Medical's new Elite software introduces Augmented Visual Electromyograph, using an algorithm to transform a subjective test into an objective science.

Projected to surpass $3.2 billion by 2032, the skin booster market is booming. Discover the science, business, and societal shifts driving this trend.

The new SecureFlex™ device aims to improve tissue sampling for diseases like pancreatic cancer, enabling more precise diagnoses and personalized treatments.

A new study reveals an AI-powered metric better predicts sleep apnea symptoms than traditional tests, promising more accurate diagnoses, especially for women.

After a dominant 2025, Planet DDS is shifting from cloud leader to AI pioneer, promising to automate workflows for the growing DSO market.

A new medical device enters real-world trials, promising to solve a critical failure point in dialysis grafts and improve life for millions of patients.

As its promising prostate cancer drug nears Phase 3, Convergent Therapeutics hires a new CPO to build the team for its next critical growth phase.

BioBridges and its legacy brands consolidate into Peritia, a new end-to-end platform designed to accelerate product development for resource-strapped teams.

With promising brain scan data, a deep therapeutic pipeline, and a cash runway into 2027, Radiopharm Theranostics is gaining significant momentum.

A new study in Nature Medicine shows a fasting-mimicking diet led to high remission rates in Crohn's patients, heralding a new era for 'Food as Medicine'.

Finnish firm GlucoModicum publishes research validating its needle-free tech, a major step toward ending painful finger pricks for diabetes management.

Curitics Health Solutions' new AI platform targets administrative bloat, promising to free clinicians from paperwork and speed up patient care approvals.

Top scientists, survivors, and industry leaders are uniting to accelerate a new generation of cancer vaccines, moving them from lab to patient faster than ever.